micron-logo_black_rgb.png
Micron Technology, Inc. Reports Results for the Fourth Quarter and Full Year of Fiscal 2024
September 25, 2024 16:07 ET | Micron Technology, Inc.
BOISE, Idaho, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its fourth quarter and full year of fiscal 2024, which ended August 29, 2024. ...
Concentrix Logo.png
Concentrix Introduces Intelligent Experience Technology Product Suite with Launch of iX Hello™
September 25, 2024 16:06 ET | Concentrix Corporation
Concentrix Introduces Intelligent Experience Technology Product Suite with Launch of iX Hello™
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
September 25, 2024 16:05 ET | Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
TelesisBio_Logo_RGB.png
Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
September 25, 2024 16:05 ET | Telesis Bio
SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create efficient...
Concentrix Logo.png
Concentrix Reports Third Quarter 2024 Results
September 25, 2024 16:05 ET | Concentrix Corporation
Delivers revenue above the midpoint of guidance and profit within guidance rangeReturns $60 million to shareholders in the quarter through share repurchases and dividends and raises quarterly dividend...
lumos.png
Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024
September 25, 2024 16:05 ET | Lumos Pharma, Inc.
AUSTIN, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that an...
SEAL LOGO.png
SEALSQ Announces Unaudited First Half 2024 Financial Results and Updates on Strategic Business Initiatives
September 25, 2024 16:05 ET | SEALSQ
Geneva, Switzerland, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Schedules Conference Call and Webcast for Thursday, September 26 at 9:00 am ET (3:00 pm CET) Strategic initiatives include launch of...
Rush-Enterprises-Logo-Color.png
Rush Enterprises, Inc. Conference Call Advisory for Third Quarter 2024 Earnings Results
September 25, 2024 16:05 ET | Rush Enterprises, Inc.
RUSH ENTERPRISES, INC. CONFERENCE CALL ADVISORY FOR THIRD QUARTER 2024 EARNINGS RESULTS
BioVie Logo.jpg
BioVie Inc. Announces Closing of Public Offering
September 25, 2024 16:05 ET | BioVie, Inc.
CARSON CITY, Nev., Sept. 25, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic...
MDxHealth Logo_Full Color_RGB.png
MDxHealth Announces Launch of Offering of Ordinary Shares
September 25, 2024 16:05 ET | mdxhealth
MDxHealth Announces Launch of Offering of Ordinary Shares IRVINE, CA, and HERSTAL, BELGIUM –September 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (“mdxhealth” or the “Company”), a...